GlassScriptPrepare for your visit
Michael W Mccall
MOHS-Micrographic Surgery · Louisville, KY · NPI 1518973841
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$552.33
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Novartis Pharmaceuticals Corporation $215.63
- Boehringer Ingelheim Pharmaceuticals, INC. $89.98
- Abbvie INC. $79.95
- Lilly USA, LLC $52.84
- Janssen Biotech, INC. $43.91
- Helsinn Therapeutics (U.S.), INC. $38.85
Drugs and devices associated with these payments
Spevigo Skyrizi Valchlor
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/492067/michael-w-mccall